The paired ESD and ESCC exhibited a highly comparable mutational landscape; ESD not associated with ESCC displayed a lower mutational profile (TP53 mutations in 30.8% compared with 95.6% and 97.8% in tumor-associated ESD and ESS, respectively) [11]. Here, TP53 is linked to neoplasm.